Both male circumcision and the new HPV vaccine have been called “no-brainers” in the fight to reduce HIV and HPV infection rates. But are they really the magic bullet solutions that they seem to be?
A new study has found that administering the HPV vaccine based on a woman’s risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.
Despite the recognized benefits of universal programs aimed at young girls there is still a need to raise concerns about vulnerable and disadvantaged groups of women who are simply falling through the cracks.